US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist
  • 9.430
  • -0.180-1.87%
Close Oct 18 16:00 ET
  • 9.430
  • 0.0000.00%
Post 20:02 ET
344.40MMarket Cap-3185P/E (TTM)

ITeos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
35M
0
-95.29%12.6M
0
0
0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
-81.31%19.49M
Operating revenue
--35M
--0
-95.29%12.6M
--0
--0
--0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
-81.31%19.49M
Cost of revenue
Gross profit
Operating expense
15.24%47.75M
24.79%45.48M
14.08%157.48M
5.98%37.24M
24.23%42.23M
9.21%41.44M
17.70%36.45M
53.91%138.04M
35.02%35.14M
45.44%33.99M
Selling and administrative expenses
-7.28%12.46M
6.51%12.7M
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
22.82%10.76M
-General and administrative expense
-7.28%12.46M
6.51%12.7M
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
22.82%10.76M
Research and development costs
25.78%36.71M
34.89%34.53M
16.37%113.3M
9.27%27.78M
28.02%30.64M
8.46%29.19M
21.34%25.6M
63.99%97.36M
46.22%25.42M
48.63%23.93M
Other operating expenses
-19.41%-1.42M
-62.43%-1.75M
-90.44%-6.21M
-110.21%-2.9M
-50.14%-1.05M
-169.93%-1.19M
-44.70%-1.08M
67.95%-3.26M
-44.31%-1.38M
53.12%-698K
Operating profit
69.23%-12.75M
-90.68%-45.48M
-211.81%-144.89M
-298.48%-37.24M
-191.11%-42.23M
-1,197.93%-41.44M
-119.62%-23.85M
-49.20%129.59M
-91.25%18.76M
-117.93%-14.51M
Net non-operating interest income expense
-2.80%7.82M
-5.92%7.39M
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
6.97M
3.24M
Non-operating interest income
-2.80%7.82M
-5.92%7.39M
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
--6.97M
--3.24M
Other net income (expense)
-79.45%67K
26.93%2.09M
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
209.36%9.28M
Other non- operating income (expenses)
-79.45%67K
26.93%2.09M
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
209.36%9.28M
Income before tax
85.28%-4.87M
-150.85%-36M
-173.30%-109.03M
-223.93%-28.19M
-1,582.88%-33.42M
-491.66%-33.07M
-112.01%-14.35M
-42.01%148.74M
-89.85%22.75M
-102.74%-1.99M
Income tax
83.52%2.26M
84.65%2.21M
-93.07%3.61M
3.05%2.36M
60.33%-1.18M
-56.27%1.23M
-97.60%1.2M
24.18%52.08M
-94.15%2.29M
-207.43%-2.98M
Net income
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
Net income continuous Operations
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
Minority interest income
Net income attributable to the parent company
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
Basic earnings per share
81.25%-0.18
-143.18%-1.07
-215.81%-3.15
-246.55%-0.85
-3,100.00%-0.9
-700.00%-0.96
-122.45%-0.44
-55.41%2.72
-88.97%0.58
-98.48%0.03
Diluted earnings per share
81.25%-0.18
-143.18%-1.07
-223.05%-3.15
-254.55%-0.85
-3,100.00%-0.9
-740.00%-0.96
-124.18%-0.44
-54.93%2.56
-88.75%0.55
-98.39%0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 35M0-95.29%12.6M000-91.74%12.6M-22.38%267.63M-77.59%53.91M-81.31%19.49M
Operating revenue --35M--0-95.29%12.6M--0--0--0-91.74%12.6M-22.38%267.63M-77.59%53.91M-81.31%19.49M
Cost of revenue
Gross profit
Operating expense 15.24%47.75M24.79%45.48M14.08%157.48M5.98%37.24M24.23%42.23M9.21%41.44M17.70%36.45M53.91%138.04M35.02%35.14M45.44%33.99M
Selling and administrative expenses -7.28%12.46M6.51%12.7M14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M22.82%10.76M
-General and administrative expense -7.28%12.46M6.51%12.7M14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M22.82%10.76M
Research and development costs 25.78%36.71M34.89%34.53M16.37%113.3M9.27%27.78M28.02%30.64M8.46%29.19M21.34%25.6M63.99%97.36M46.22%25.42M48.63%23.93M
Other operating expenses -19.41%-1.42M-62.43%-1.75M-90.44%-6.21M-110.21%-2.9M-50.14%-1.05M-169.93%-1.19M-44.70%-1.08M67.95%-3.26M-44.31%-1.38M53.12%-698K
Operating profit 69.23%-12.75M-90.68%-45.48M-211.81%-144.89M-298.48%-37.24M-191.11%-42.23M-1,197.93%-41.44M-119.62%-23.85M-49.20%129.59M-91.25%18.76M-117.93%-14.51M
Net non-operating interest income expense -2.80%7.82M-5.92%7.39M179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M6.97M3.24M
Non-operating interest income -2.80%7.82M-5.92%7.39M179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M--6.97M--3.24M
Other net income (expense) -79.45%67K26.93%2.09M-47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M209.36%9.28M
Other non- operating income (expenses) -79.45%67K26.93%2.09M-47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M209.36%9.28M
Income before tax 85.28%-4.87M-150.85%-36M-173.30%-109.03M-223.93%-28.19M-1,582.88%-33.42M-491.66%-33.07M-112.01%-14.35M-42.01%148.74M-89.85%22.75M-102.74%-1.99M
Income tax 83.52%2.26M84.65%2.21M-93.07%3.61M3.05%2.36M60.33%-1.18M-56.27%1.23M-97.60%1.2M24.18%52.08M-94.15%2.29M-207.43%-2.98M
Net income 79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K
Net income continuous Operations 79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K
Minority interest income
Net income attributable to the parent company 79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K
Basic earnings per share 81.25%-0.18-143.18%-1.07-215.81%-3.15-246.55%-0.85-3,100.00%-0.9-700.00%-0.96-122.45%-0.44-55.41%2.72-88.97%0.58-98.48%0.03
Diluted earnings per share 81.25%-0.18-143.18%-1.07-223.05%-3.15-254.55%-0.85-3,100.00%-0.9-740.00%-0.96-124.18%-0.44-54.93%2.56-88.75%0.55-98.39%0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data